MIZUHO CORPORATION

Mizuho Corporation specializes in surgical instruments and operating room accessories. Their portfolio includes aneurysm clips and appliers for vascular procedures, reusable bone cutting forceps, neurosurgical brain retraction systems, and reusable suction cannulas. They also produce operating table accessories like mattresses and accessory trolleys, as well as tools like atraumatic suction tubes and malleable dissectors for open surgery. These devices cater to vascular, neurosurgical, and general surgical applications.

Mizuho Corporation is headquartered in Japan. While the company’s location influences its regulatory framework—such as compliance with Japanese medical device regulations—the specific regulatory status of its devices depends on individual product authorizations in markets like the EU or the US. For example, their devices are listed in the EUDAMED database and the FDA’s UDI system, indicating their presence in those markets, but the company itself is not approved; rather, its devices undergo separate authorization processes.

Mizuho Corporation’s devices are listed in the EUDAMED database and the FDA’s UDI (Unique Device Identifier) system. Inclusion in these databases is important because they serve as official registries for tracking medical devices across the EU and the US. EUDAMED ensures transparency in the EU market, while the FDA’s UDI system supports traceability and post-market surveillance in the US. Listing in these systems helps healthcare providers, regulators, and patients verify the legitimacy and compliance status of specific devices.

Mizuho Corporation’s devices fall under EU Class I and Class II classifications. In the EU, Class I devices are generally considered low-risk, such as basic surgical accessories like operating table mattresses or accessory trolleys, and typically require a simple conformity assessment. Class II devices, which may include aneurysm clips or neurosurgical tools, pose moderate risks and require more rigorous evaluation, such as involvement of a Notified Body to ensure safety and performance. The classification determines the regulatory pathway and documentation required for market authorization.

Yes, aneurysm clips and appliers are often classified as higher-risk devices compared to simpler accessories like operating table mattresses. In the EU, these would typically fall under Class II due to their critical role in vascular procedures, where even minor failures could pose significant risks to patients. This classification requires additional scrutiny, such as clinical evaluations or involvement of a Notified Body, to ensure their safety and effectiveness before authorization. The classification ensures that devices used in high-stakes procedures undergo thorough regulatory oversight.